EndoRel Biosciences Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

EndoRel Biosciences General Information

Description

Developer of an endosomal release platform designed for targeted intracellular delivery. The company aims to combine endosome-to-cytosol delivery (ECD) technology with small molecule, antisense, or protein-based drugs, or complementary delivery technologies, including nanoparticles, providing partners and collaborators with a tool for creating the next generation of therapeutics supporting human health and well-being.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 4640 South Macadam Avenue
  • Unit 200
  • Portland, OR 97239
  • United States
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 4640 South Macadam Avenue
  • Unit 200
  • Portland, OR 97239
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EndoRel Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 07-May-2024 Completed Startup
To view EndoRel Biosciences’s complete valuation and funding history, request access »

EndoRel Biosciences Patents

EndoRel Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024036315-A1 Peptide-based delivery agent and method of making and using the same Inactive 12-Aug-2022
JP-2025528284-A Peptide-based delivery agents and methods of making and using same Pending 12-Aug-2022

EndoRel Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EndoRel Biosciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Oregon Bioscience Incubator Accelerator/Incubator
To view EndoRel Biosciences’s complete investors history, request access »

EndoRel Biosciences FAQs

  • When was EndoRel Biosciences founded?

    EndoRel Biosciences was founded in 2021.

  • Where is EndoRel Biosciences headquartered?

    EndoRel Biosciences is headquartered in Portland, OR.

  • What is the size of EndoRel Biosciences?

    EndoRel Biosciences has 2 total employees.

  • What industry is EndoRel Biosciences in?

    EndoRel Biosciences’s primary industry is Biotechnology.

  • Is EndoRel Biosciences a private or public company?

    EndoRel Biosciences is a Private company.

  • What is EndoRel Biosciences’s current revenue?

    The current revenue for EndoRel Biosciences is .

  • Who are EndoRel Biosciences’s investors?

    Oregon Bioscience Incubator has invested in EndoRel Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process